<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>alphaIIbbeta3 interaction with fibrinogen promotes Src-dependent platelet spreading in vitro </plain></SENT>
<SENT sid="1" pm="."><plain>To determine the consequences of this outside-in signaling pathway in vivo, a "beta3(Delta760-762)" knockin mouse was generated that lacked the 3 C-terminal beta3 residues (arginine-glycine-threonine [RGT]) necessary for alphaIIbbeta3 interaction with c-Src, but retained beta3 residues necessary for talin-dependent fibrinogen binding </plain></SENT>
<SENT sid="2" pm="."><plain>beta3(Delta760-762) mice were compared with <z:mp ids='MP_0002169'>wild-type</z:mp> beta3(+/+) littermates, beta3(+/-) heterozygotes, and knockin mice where beta3 RGT was replaced by beta1 C-terminal cysteine-glycine-lysine (EGK) to potentially enable signaling by Src kinases other than c-Src </plain></SENT>
<SENT sid="3" pm="."><plain>Whereas beta3(+/+), beta3(+/-) and beta3/beta1(EGK) platelets spread and underwent tyrosine phosphorylation normally on fibrinogen, beta3(Delta760-762) platelets spread poorly and exhibited reduced tyrosine phosphorylation of c-Src substrates, including beta3 (Tyr(747)) </plain></SENT>
<SENT sid="4" pm="."><plain>Unlike control mice, beta3(Delta760-762) mice were protected from carotid artery <z:mp ids='MP_0005048'>thrombosis</z:mp> after vessel injury with FeCl(3) </plain></SENT>
<SENT sid="5" pm="."><plain>Some beta3(Delta760-762) mice exhibited prolonged tail <z:mp ids='MP_0001914'>bleeding</z:mp> times; however, none demonstrated spontaneous <z:mp ids='MP_0001914'>bleeding</z:mp>, excess <z:mp ids='MP_0001914'>bleeding</z:mp> after surgery, fecal blood loss, or <z:hpo ids='HP_0001903'>anemia</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Fibrinogen binding to beta3(Delta760-762) platelets was <z:mpath ids='MPATH_458'>normal</z:mpath> in response to saturating concentrations of protease-activated receptor 4 or <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> VI <z:chebi fb="4" ids="48705">agonists</z:chebi>, but responses to <z:chebi fb="3" ids="16335">adenosine</z:chebi> <z:chebi fb="2" ids="18361">diphosphate</z:chebi> were impaired </plain></SENT>
<SENT sid="7" pm="."><plain>Thus, deletion of beta3 RGT disrupts c-Src-mediated alphaIIbbeta3 signaling and confers protection from <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>Consequently, targeting alphaIIbbeta3 signaling may represent a feasible antithrombotic strategy </plain></SENT>
</text></document>